FDA Puts Strict Limits On Johnson & Johnson COVID-19 Vaccine
The FDA said in a statement that the change is being made because of the risk of a rare and dangerous clotting condition called thrombosis with thrombocytopenia syndrome (TTS) after receiving the vaccine.